BPG is committed to discovery and dissemination of knowledge
Observational Study
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Dec 26, 2025; 17(12): 112126
Published online Dec 26, 2025. doi: 10.4330/wjc.v17.i12.112126
Predictors of life-threatening events in adult patients with left ventricular noncompaction
Olga V Blagova, Nadezhda V Varionchik, Ekaterina V Pavlenko, Vsevolod P Sedov, Yulia A Lutokhina
Olga V Blagova, Nadezhda V Varionchik, Ekaterina V Pavlenko, Yulia A Lutokhina, Division of Internal Medicine No. 1, Department of Cardiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
Vsevolod P Sedov, Division of Radiology and Radiation Therapy, Department of Cardiology, Functional Diagnostics and Ultrasound, I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow 119048, Russia
Author contributions: Blagova OV designed and supervised the study; Blagova OV, Varionchik NV, and Lutokhina YA conducted the study; Varionchik NV and Lutokhina YA wrote the original draft of the manuscript; Pavlenko EV contributed to the data analysis; Sedov VP provided clinical advice. All authors read and approved the final version of the manuscript.
Institutional review board statement: The study was approved by the Ethics Committee of the I.M. Sechenov First Moscow State Medical University.
Informed consent statement: All patients signed a voluntary informed consent to participate in the study.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Data sharing statement: Please contact the corresponding author for details.
Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yulia A Lutokhina, MD, PhD, Professor, Division of Internal Medicine No. 1, Department of Cardiology, I.M. Sechenov First Moscow State Medical University (Sechenov University), 8-2 Trubetskaya Street, Moscow 119048, Russia. lutokhina_yu_a@staff.sechenov.ru
Received: July 18, 2025
Revised: September 17, 2025
Accepted: October 30, 2025
Published online: December 26, 2025
Processing time: 159 Days and 12.4 Hours
Abstract
BACKGROUND

Left ventricular noncompaction (LVNC) is a genetic cardiomyopathy. It is characterized by intensely developed trabeculae in the ventricles with deep intertrabecular lacunae. LVNC manifests as arrhythmias and heart failure with a predisposition for thrombus formation.

AIM

To study predictors of arrhythmic, thromboembolic events and adverse outcomes (death/transplantation) in adult patients with LVNC.

METHODS

Adult patients with LVNC were included (n = 125; mean follow-up: 14 months). Electrocardiography, echocardiography, and 24-hour electrocardiography monitoring were performed. Other procedures were conducted for some patients including: Coronary angiography; cardiac magnetic resonance imaging; cardiac computed tomography; genetic testing; myocardial pathological examination; and anti-cardiac antibody level estimation. Primary endpoints were death, heart transplantation, combined endpoint (death + transplantation), and sudden cardiac death. Secondary endpoints were intracardiac thrombosis, embolic events, myocardial infarction, sustained ventricular tachycardia (VT), and implantable cardioverter-defibrillator intervention.

RESULTS

LVNC manifestations included non-sustained VT, thrombosis/embolism, sustained VT, and sudden cardiac death. Non-sustained VT was associated with the New York Heart Association (NYHA) chronic heart failure (CHF) class, poor R-wave progression, superimposed myocarditis, and higher mortality. Thrombosis/embolism was associated with NYHA CHF class ≥ 3, right ventricular end-diastolic diameter ≥ 3 cm, right atrium volume ≥ 67 mL, left ventricle end-diastolic diameter ≥ 6.3 cm, and velocity time integral ≤ 11.2 cm. Sustained VT was associated with premature ventricular contractions (PVCs), low QRS voltage, and atrioventricular block. PVCs > 500/day were predictive of defibrillator intervention. Fatal outcomes were associated with E wave/A wave ratio > 1.9, left ventricle ejection fraction < 35%, NYHA CHF class ≥ 3, VT, and myocarditis.

CONCLUSION

Frequent PVCs, non-sustained VT, low QRS voltage, and signs of systolic dysfunction on echocardiogram are predictors of life-threatening events in patients with LVNC.

Keywords: Left ventricular noncompaction; Predictors; Arrhythmic events; Thromboembolic events; Adverse outcomes; Myocarditis; Heart failure

Core Tip: Left ventricular noncompaction (LVNC) is associated with a high risk of thrombosis/embolism and arrhythmias. We investigated the predictors of these types of events in 125 patients with LVNC over an average follow-up of 14 months. Following electrocardiography, echocardiography, 24-hour electrocardiogram monitoring, cardiac magnetic resonance imaging, cardiac computed tomography, genetic testing, myocardial morphological examination, and laboratory examination, the acquired data were analyzed. Frequent premature ventricular contractions, non-sustained ventricular tachycardia, low QRS voltage, and signs of systolic dysfunction must be considered for risk assessment in patients with LVNC.